Table of Contents PART 01: Executive summary Highlights PART 02: Scope of the report Market overview Top-vendor offerings PART 03: Market research methodology Research methodology Economic indicators PART 04: Introduction Key market highlights Cervical cancer: An overview PART 05: Market landscape Market overview Market size and forecast Five forces analysis PART 06: Market segmentation by test type Pap smear test HPV testing Global cervical cancer Pap smear test market Global cervical cancer HPV testing market PART 07: Market segmentation by technology ELISA FISH NASBA PCR Multichromatic staining and microscopy PART 08: Market segmentation by method Cytopathological method Molecular method PART 09: Market segmentation by end-user Hospitals Clinical diagnostic laboratories Homecare Others PART 10: Geographical segmentation Cervical cancer diagnostic testing market in Americas Cervical cancer diagnostic testing market in EMEA Cervical cancer diagnostic testing market in APAC PART 11: Buying criteria PART 12: Market drivers Rising prevalence of cervical cancer risk factors Growing adoption of HPV testing Reimbursement policies Increasing global activities by public organizations PART 13: Impact of drivers PART 14: Market challenges Rising awareness toward cervical cancer over-screening Less public awareness and presence of social barriers Limited number of health clinics in developing countries Availability of visual inspection methods PART 15: Impact of drivers and challenges PART 16: Market trends Development of new diagnostic platforms Expansion into emerging markets Emergence of novel biomarkers Rise in use of HPV home-testing kits PART 17: Vendor landscape Competitive scenario Geographical presence of key vendors Key news PART 18: Key vendor analysis Abbott Molecular Becton, Dickinson & Company (BD) Hologic QIAGEN Quest Diagnostics Roche Molecular Diagnostics Other prominent vendors PART 19: Appendix List of abbreviations PART 20: Explore Technavio   List of Exhibits Exhibit 01: Product offerings Exhibit 02: Global cervical cancer diagnostic testing market: Analysis Exhibit 03: Global incidence of cervical cancer 2012-2020 (thousands) Exhibit 04: Incidences of cervical cancer in developing and developed countries 2012-2020 (in thousands) Exhibit 05: Market overview: Global cervical cancer diagnostic testing market Exhibit 06: Global cervical cancer diagnostic testing market ($ billions) Exhibit 07: Global cervical cancer diagnostic testing market analysis: Developed and emerging markets Exhibit 08: Opportunity analysis: Global cervical cancer diagnostic testing market Exhibit 09: Five forces analysis Exhibit 10: Global cervical cancer diagnostic testing market by test type 2015 Exhibit 11: Global cervical cancer diagnostic testing market by test type 2020 Exhibit 12: Major cervical cancer diagnostic products Exhibit 13: Global cervical cancer Pap smear test market 2015-2020 ($ billions) Exhibit 14: Global cervical cancer HPV testing market 2015-2020 ($ millions) Exhibit 15: Segmentation of global cervical cancer HPV testing market by product type Exhibit 16: Global cervical cancer diagnostic testing market segmentation by test type 2015-2020 ($ millions) Exhibit 17: Global cervical cancer diagnostic testing market segmentation by test type 2015-2020 (%) Exhibit 18: List of some studies for cervical cancer screening using ELISA technique Exhibit 19: List of some studies for cervical cancer screening using FISH technique Exhibit 20: List of some studies for cervical cancer screening using NASBA technique Exhibit 21: List of some studies for cervical cancer screening using PCR technique Exhibit 22: List of some studies for cervical cancer screening using Multichromatic staining and microscopy technique Exhibit 23: Some cervical cancer diagnostic test products by technology Exhibit 24: Global cervical cancer diagnostic testing market by method 2015 Exhibit 25: Global cervical cancer diagnostic testing market by method 2020 Exhibit 26: Global cervical cancer diagnostic testing market segmentation by end users 2015 Exhibit 27: Global cervical cancer diagnostic testing market segmentation by geography 2015 Exhibit 28: Global cervical cancer diagnostic testing market segmentation by geography 2020 Exhibit 29: Region-wise market impact: Global cervical cancer diagnostics market Exhibit 30: Country-wise revenue and growth analysis Exhibit 31: Global cervical cancer diagnostic testing market: Geography lifecycle analysis 2015 Exhibit 32: Market overview: Americas Exhibit 33: Cervical cancer diagnostic testing market in Americas 2016-2020 ($ millions) Exhibit 34: Market overview: EMEA Exhibit 35: Cervical cancer diagnostic testing in EMEA 2016-2020 ($ millions) Exhibit 36: Market overview: APAC Exhibit 37: Cervical cancer diagnostic testing market in APAC 2016-2020 ($ millions) Exhibit 38: Comparison of cervical cancer incidences in developed and developing countries 2012-2020 (in thousands) Exhibit 39: Global cervical cancer diagnostic testing market segmentation by geography 2015-2020 (%) Exhibit 40: Global cervical cancer diagnostic testing market segmentation by geography 2015-2020 ($ millions) Exhibit 41: Geographical overview: Global cervical cancer diagnostic testing market Exhibit 42: Key buying criteria for cervical cancer diagnostic testing Exhibit 43: Buying criteria for cervical cancer diagnostic testing Exhibit 44: Country-wise percentage of women who smoke on a daily-basis Exhibit 45: Country-wise statistics of cervical cancer cases per 100,000 women per year Exhibit 46: Reimbursement policies in different countries Exhibit 47: Activities of CDC in collaboration with other public organizations for cervical cancer screening Exhibit 48: Impact of drivers Exhibit 49: Cervical cancer cases comparison in North-Americas and Africa Exhibit 50: Impact of drivers and challenges Exhibit 51: Expansion of global market leaders in developing countries/regions Exhibit 52: List of cervical cancer diagnostic studies for novel biomarker detection Exhibit 53: Trends and their impact Exhibit 54: Competitive structure analysis of global cervical cancer testing market 2015 Exhibit 55: Market penetration of various cervical cancer diagnostic testing manufacturers globally (2015) Exhibit 56: Competitive landscape analysis of global cervical cancer diagnostic testing market 2015 Exhibit 57: Strategic success factors of companies in global cervical cancer diagnostic testing market 2015 Exhibit 58: Leading vendors ranking 2015 Exhibit 59: Share of vendors in global cervical cancer diagnostic testing market 2015 Exhibit 60: Regional analysis of key vendors Exhibit 61: Key highlights of Abbott Molecular Exhibit 62: Abbott Molecular strength assessment Exhibit 63: Abbott Molecular strategy assessment Exhibit 64: Abbott Molecular opportunity assessment Exhibit 65: Key highlights of BD Exhibit 66: BD strength assessment Exhibit 67: BD strategy assessment Exhibit 68: BD opportunity assessment Exhibit 69: Key highlights of Hologic Exhibit 70: Hologic strength assessment Exhibit 71: Hologic strategy assessment Exhibit 72: Hologic opportunity assessment Exhibit 73: Key highlights of QIAGEN Exhibit 74: QIAGEN strength assessment Exhibit 75: QIAGEN strategy assessment Exhibit 76: QIAGEN opportunity assessment Exhibit 77: Key highlights of Quest Diagnostics Exhibit 78: Quest Diagnostics strength assessment Exhibit 79: Quest Diagnostics strategy assessment Exhibit 80: Quest Diagnostics opportunity assessment Exhibit 81: Key highlights of Roche Molecular Diagnostics Exhibit 82: Roche Molecular Diagnostics strength assessment Exhibit 83: Roche Molecular Diagnostics strategy assessment Exhibit 84: Roche Molecular Diagnostics opportunity assessment

Abbott Molecular, Becton, Dickinson & Company, Hologic, Qiagen, Quest Diagnostics, Roche Molecular Diagnostics, Arbor Vita, Autogenomics, bioMérieux, BioVantra, Cancer Genetics, Cepheid, Cervia Diagnostics, Cytoimmun, DAAN Gene, Delphi Bioscience, DiaCarta, Fujirebio, Genera Biosystems, Greiner Bio-One, Guided Therapeutics, GynaeHealth, IncellDx, Micromedic Technologies, Norchip, OncoHealth, OralDNA Labs, Seegene, Solopap International, Trovagene.